---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-000236"
form_type: "8-K"
ticker: "PTPI"
cik: "0001815903"
company_name: "Petros Pharmaceuticals, Inc."
filed_at: "2026-01-02T23:59:59+00:00"
generated_at: "2026-05-16T11:49:27.422695+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Petros Pharmaceuticals grants 7.25M RSUs to executives and directors; 50% vested immediately

## Summary
- Joshua Silverman (Chairman) receives 4,375,000 RSUs; Bruce Bernstein 1,875,000; Fady Boctor 500,000; Wayne Walker 500,000.
- 50% of each RSU grant vested on Jan 2, 2026; remaining 50% vests at six-month anniversary subject to continued service.
- Grants issued outside the company's 2020 Omnibus Incentive Compensation Plan.
- Total RSUs represent approximately 14% of current outstanding shares (est.) based on prior filings.

## SEC filing metadata
- accession: 0001104659-26-000236
- form_type: 8-K
- ticker: PTPI
- cik: 0001815903
- company_name: Petros Pharmaceuticals, Inc.
- filed_at: 2026-01-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815903/000110465926000236/0001104659-26-000236-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815903/000110465926000236/tm261703d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-000236
- JSON: https://secwatch.observer/filing/0001104659-26-000236.json
- Plain text: https://secwatch.observer/filing/0001104659-26-000236.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.